Os Therapies Incorporated (OSTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Gross Profit | 850 | 840 | 630 | 850 | 790 |
| Operating Expenses | 420 | 400 | 460 | 380 | 470 |
| Operating Income | -420 | -400 | -460 | -380 | -470 |
| Pre-tax Income | -420 | -400 | -460 | -380 | -470 |
| Net Income Continuous | -420 | -400 | -460 | -380 | -470 |
| Net Income | $-420 | $-400 | $-460 | $-380 | $-470 |
| EBITDA(a) | $-240 | $-230 | $-290 | $-120 | $-250 |